This activity is appropriate for:
House Officers, Medical Students, Nurse Practitioners, Nurses, Other Healthcare Professionals, Physician Assistants, Physicians

In the fields of:
General Medicine, Internal Medicine, Other Healthcare Professions, Rheumatology

LEARNING OBJECTIVES

At the end of this activity, participants should be able to:

1. identify the role of hydroxychloroquine in standard of care lupus management.
2. describe the role of immunosuppressants and which ones to choose in SLE.
3. list the barriers to proper care in lupus patients.
4. differentiate the patients that my benefit from voclosporin and belimumab for lupus nephritis.
5. research new therapies in the pipeline and how they may benefit patients with SLE.

ACCREDITATION

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Michigan Medical School designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.